Search Results

A drug that boosts strength in injured or aging mice restores connections between nerves and muscle and suggests ways to combat weakness in humans due to aging, injury or disease.

Scientists discover a biomarker in stroke survivors, suggesting that chemical changes after stroke can lead to depression. The findings may pave the way toward treatment.

Fat from olive oil and nuts boosts the numbers of two key cellular structures and protects membranes from damage, lengthening the lives of laboratory worms, Stanford Medicine-led study finds.

Statins designed to lower cholesterol have long been noted to work in mysterious ways to improve other aspects of cardiovascular health. A Stanford Medicine-led study uncovers how they do it.

A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.

A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.

Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.

Stanford Medicine researchers and their collaborators have identified a molecule that staves off hunger post-exercise.

Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.

The structure of a critical cellular-signaling molecule has finally been discovered by Stanford researchers. The finding may lead to new therapies.